Loading company…
Prime Medicine develops gene-editing technology intended to address genetic diseases.
Founded in 2019 and based in Massachusetts, Prime Medicine develops Prime Editing, a gene-editing technology designed to restore gene function. David R. Liu and Andrew Anzalone co-founded the company. Alphabet acquired Prime Medicine in May 2024.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in